Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples.
about
Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA)The Navigation Guide - evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growthEffects of Environmental Exposures on Fetal and Childhood Growth TrajectoriesEnvironmental influences on reproductive health: the importance of chemical exposuresConcentrations of persistent organic pollutants in maternal and cord blood from the maternal-infant research on environmental chemicals (MIREC) cohort studyRelationships of chemical concentrations in maternal and cord blood: a review of available data.Perfluorinated compounds in umbilical cord blood and adverse birth outcomesDietary predictors and plasma concentrations of perfluorinated compounds in a coastal population from northern Norway.Perfluorooctanoate and neuropsychological outcomes in childrenPerfluorooctanoate exposure and major birth defects.Changes in serum concentrations of maternal poly- and perfluoroalkyl substances over the course of pregnancy and predictors of exposure in a multiethnic cohort of Cincinnati, Ohio pregnant women during 2003-2006.The Navigation Guide - evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growthThe Navigation Guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth.Partition of environmental chemicals between maternal and fetal blood and tissues.Congenital anomalies, labor/delivery complications, maternal risk factors and their relationship with perfluorooctanoic acid (PFOA)-contaminated public drinking water.Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transfer.Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age.Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health ProjectPolyfluoroalkyl compounds in Texas children from birth through 12 years of age.Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study.Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water.Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort Study.Phthalates and perfluorooctanesulfonic acid in human amniotic fluid: temporal trends and timing of amniocentesis in pregnancy.The Association of Prenatal Exposure to Perfluorinated Chemicals with Maternal Essential and Long-Chain Polyunsaturated Fatty Acids during Pregnancy and the Birth Weight of Their Offspring: The Hokkaido Study.Comparison of polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: a pilot studyEffects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposuresAssociations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK)Exposure to PFOA and PFOS and fetal growth: a critical merging of toxicological and epidemiological data.Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages.Maternal and Neonatal Levels of Perfluoroalkyl Substances in Relation to Gestational Weight GainPlacental transfer of persistent organic pollutants: a preliminary study on mother-newborn pairs.Perfluoroalkyl Acids in Maternal Serum and Indices of Fetal Growth: The Aarhus Birth Cohort.Prenatal Exposure to Perfluorocarboxylic Acids (PFCAs) and Fetal and Postnatal Growth in the Taiwan Maternal and Infant Cohort Study.Perfluorinated compounds in food: a global perspective.Biomonitoring of human fetal exposure to environmental chemicals in early pregnancy.Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: a systematic review.Human exposure to environmental contaminants and congenital anomalies: a critical review.Effects of perfluorinated compounds on development of zebrafish embryos.Perfluoroalkyl substances with isomer analysis in umbilical cord serum in China.Perfluorooctanoic acid binds to peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation in 3T3-L1 adipocytes.
P2860
Q24632957-540DFA49-2B10-492B-87B1-6FC41B5CE1C3Q26851809-3A22BF98-80E1-4E66-928E-F6727B6EDA86Q28079540-F92F37B9-4834-4C89-9CC8-31DE1DA487F4Q28396514-155D9170-A3C7-4099-8216-7759390832A2Q28833625-B3D655A2-8525-4AE1-A945-27708A1A5BFAQ30805001-A76CF191-E0EF-48BC-ADEA-2C388258E8D6Q31083691-6D691C89-91A0-4319-B6A0-CC2522AB4179Q33606598-4DB24B29-C2AC-4D83-9C46-11D2CFFCFF5EQ33608031-7568E816-A642-4996-BD2E-37C4FD159343Q33984406-E22FD86E-E6E3-4AAE-BE6B-1FDB49249138Q34074733-742E0FF1-E897-4FCD-88EE-BB0D0E4A5E36Q34275308-2544BE24-C5A6-4F1A-B182-BBD9817877EBQ34275367-24431481-27A7-4217-A0AE-DC5692085F8EQ34540744-8C9C8CCD-E945-4766-96D7-2285E36D0AE8Q34570340-9697D647-DBA1-4DAA-9EF9-EFEEC9A8EF13Q35579871-C1AAF6FE-3D85-4E51-BDC8-0DE1716D28E5Q35591930-EDF4A0CE-C178-4798-B49B-F017FE167E09Q35682907-55D33461-0409-4D47-B483-E0B231264295Q35920263-998BEE18-B96D-4E04-8F8C-DA94312620D5Q35941792-A35EB1B6-CAAF-4E9B-9EBA-B4780BAA031BQ35941864-2B448C7F-0A9D-4497-865D-2A5D8E3CF866Q36023451-749E246A-756F-4BCD-B4C5-A785086E2A06Q36064764-58CB7C14-AE9A-49D2-8B65-71E6DDEEA611Q36112054-3747CD88-8DC4-4F8A-96EC-D80BB36B232BQ36205129-FD084BEE-DE2C-4CA5-A278-58671475B4D2Q36336680-768499C1-9B2A-4697-B02C-7B0BEE9186B0Q36350881-AC480935-3752-41EB-9F49-DF9856F26349Q36406073-4B1299D0-3E5F-4A46-9D83-FD17E084C560Q36411181-725B7F10-2BCD-4A56-BF7B-68DB21DFA576Q36513368-825FC803-6173-47A9-B899-3839F270456CQ36792320-8873912D-536B-4D49-94F8-86FEA5504BBBQ36968190-18DD5056-72FD-4D13-BF8E-EA66563BFE21Q37385404-ECA3A2DB-2B33-4557-B135-EAF5B7D9150BQ37906657-A21263BF-C04C-4A86-B8C5-5B12B1373AD8Q38211781-67362709-43D3-4760-A98A-DA869C939FB2Q38265262-DFAFBA76-1F0F-45C2-8211-60F6AFBEC660Q38967889-AC067524-2BD5-44F2-AB02-24DDDF9BEC9DQ40051385-9F629C64-8573-4824-9A1F-E6467774337FQ40251746-F2EE05B9-F578-4DD3-BE96-BB083CDC0D74Q42832121-4E49921A-1D20-4EDF-96C9-AEC2050BD208
P2860
Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Serum levels of perfluoroalkyl ...... umbilical cord blood samples.
@ast
Serum levels of perfluoroalkyl ...... umbilical cord blood samples.
@en
Serum levels of perfluoroalkyl ...... umbilical cord blood samples.
@nl
type
label
Serum levels of perfluoroalkyl ...... umbilical cord blood samples.
@ast
Serum levels of perfluoroalkyl ...... umbilical cord blood samples.
@en
Serum levels of perfluoroalkyl ...... umbilical cord blood samples.
@nl
prefLabel
Serum levels of perfluoroalkyl ...... umbilical cord blood samples.
@ast
Serum levels of perfluoroalkyl ...... umbilical cord blood samples.
@en
Serum levels of perfluoroalkyl ...... umbilical cord blood samples.
@nl
P2093
P1476
Serum levels of perfluoroalkyl ...... d umbilical cord blood samples
@en
P2093
Brian Stewart
Cariton Kubwabo
Rocio Monroy
Stephanie Atkinson
Warren G Foster
P356
10.1016/J.ENVRES.2008.06.001
P577
2008-07-22T00:00:00Z